|
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Continuing Education |
1 UMR 678 INSERM-UPMC, CHU Pitié-Salpêtrière, Paris, France; 2 Nuclear Medicine Department, HIA Val-de-Grâce, Paris, France; and 3 Department of Radiology, University of California, San Francisco, California
Correspondence: For correspondence or reprints contact: Irène Buvat, UMR 678 INSERM, 91 Boulevard de l'Hôpital, CHU Pitié-Salpêtrière, 75634 Paris Cedex 13, France. E-mail: buvat{at}imed.jussieu.fr
PET has the invaluable advantage of being intrinsically quantitative, enabling accurate measurements of tracer concentrations in vivo. In PET tumor imaging, indices characterizing tumor uptake, such as standardized uptake values, are becoming increasingly important, especially in the context of monitoring the response to therapy. However, when tracer uptake in small tumors is measured, large biases can be introduced by the partial-volume effect (PVE). The purposes of this article are to explain what PVE is and to describe its consequences in PET tumor imaging. The parameters on which PVE depends are reviewed. Actions that can be taken to reduce the errors attributable to PVE are described. Various PVE correction schemes are presented, and their applicability to PET tumor imaging is discussed.
Key Words: PET tumor imaging partial volume standardized uptake value
* NOTE: FOR CE CREDIT, YOU CAN ACCESS THIS ACTIVITY THROUGH THE SNM WEB SITE (http://www.snm.org/ce_online) THROUGH JUNE 2008.
No potential conflict of interest relevant to this article was reported.
COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.
Related articles in JNM:
This article has been cited by other articles:
![]() |
M. Sydoff, H. Uusijarvi, S. Leide-Svegborn, and S. Mattsson ABSOLUTE QUANTIFICATION OF ACTIVITY CONTENT FROM PET IMAGES USING THE PHILIPS GEMINI TF PET/CT SYSTEM Radiat Prot Dosimetry, March 11, 2010; (2010) ncq087v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Visser, O. C. Boerman, and W. J.G. Oyen SUV: From Silly Useless Value to Smart Uptake Value J. Nucl. Med., February 1, 2010; 51(2): 173 - 175. [Full Text] [PDF] |
||||
![]() |
P. Tylski, S. Stute, N. Grotus, K. Doyeux, S. Hapdey, I. Gardin, B. Vanderlinden, and I. Buvat Comparative Assessment of Methods for Estimating Tumor Volume and Standardized Uptake Value in 18F-FDG PET J. Nucl. Med., February 1, 2010; 51(2): 268 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Seo, C. M. Aparici, M. R. Cooperberg, B. R. Konety, and R. A. Hawkins In Vivo Tumor Grading of Prostate Cancer Using Quantitative 111In-Capromab Pendetide SPECT/CT J. Nucl. Med., January 1, 2010; 51(1): 31 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Werner, J. A. Parker, G. M. Kolodny, J. R. English, and M. R. Palmer Respiratory Gating Enhances Imaging of Pulmonary Nodules and Measurement of Tracer Uptake in FDG PET/CT Am. J. Roentgenol., December 1, 2009; 193(6): 1640 - 1645. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Willmann, R. Paulmurugan, M. Rodriguez-Porcel, W. Stein, T. J. Brinton, A. J. Connolly, C. H. Nielsen, A. M. Lutz, J. Lyons, F. Ikeno, et al. Imaging Gene Expression in Human Mesenchymal Stem Cells: From Small to Large Animals1 Radiology, July 1, 2009; 252(1): 117 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Boellaard Standards for PET Image Acquisition and Quantitative Data Analysis J. Nucl. Med., May 1, 2009; 50(Suppl_1): 11S - 20S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Willmann, R. Paulmurugan, M. Rodriguez-Porcel, W. Stein, T. J. Brinton, A. J. Connolly, C. H. Nielsen, A. M. Lutz, J. Lyons, F. Ikeno, et al. Imaging Gene Expression in Human Mesenchymal Stem Cells: From Small to Large Animals Radiology, April 14, 2009; (2009) 2513081616. [Abstract] [Full Text] |
||||
![]() |
J. J. Fox and H. W. Strauss One Step Closer to Imaging Vulnerable Plaque in the Coronary Arteries J. Nucl. Med., April 1, 2009; 50(4): 497 - 500. [Full Text] [PDF] |
||||
![]() |
M. Nakajo, S. Jinnouchi, Y. Tashiro, H. Shirahama, E. Sato, C. Koriyama, and M. Nakajo Effect of Clinicopathologic Factors on Visibility of Colorectal Polyps with FDG PET Am. J. Roentgenol., March 1, 2009; 192(3): 754 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Carkaci, H. A. Macapinlac, M. Cristofanilli, O. Mawlawi, E. Rohren, A. M. Gonzalez Angulo, S. Dawood, E. Resetkova, H. T. Le-Petross, and W.-T. Yang Retrospective Study of 18F-FDG PET/CT in the Diagnosis of Inflammatory Breast Cancer: Preliminary Data J. Nucl. Med., February 1, 2009; 50(2): 231 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Kidd and P. W. Grigsby Intratumoral Metabolic Heterogeneity of Cervical Cancer Clin. Cancer Res., August 15, 2008; 14(16): 5236 - 5241. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Buvat, S. L. Bacharach, and M. Soret Reply: Feasibility of Automated Partial-Volume Correction of SUVs in Current PET/CT Scanners: Can Manufacturers Provide Integrated, Ready-to-Use Software? J. Nucl. Med., June 1, 2008; 49(6): 1032 - 1033. [Full Text] [PDF] |
||||
![]() |
J. R. Bading and A. F. Shields Imaging of Cell Proliferation: Status and Prospects J. Nucl. Med., June 1, 2008; 49(Suppl_2): 64S - 80S. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Basu and A. Alavi Feasibility of Automated Partial-Volume Correction of SUVs in Current PET/CT Scanners: Can Manufacturers Provide Integrated, Ready-to-Use Software? J. Nucl. Med., June 1, 2008; 49(6): 1031 - 1032. [Full Text] [PDF] |
||||
![]() |
A. J. de Langen, V. E. M. van den Boogaart, J. T. Marcus, and M. Lubberink Use of H215O-PET and DCE-MRI to Measure Tumor Blood Flow Oncologist, June 1, 2008; 13(6): 631 - 644. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |